News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on CannPal.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: CannPal wins a global licence for CSIRO’s tech to treat inflammation in animals; shares spike 74pc
News
10 at 10: These ASX stocks are hitting the target today
Health & Biotech
Cannabis: ‘You’re the one that I want!’ Cann Global picks up Olivia Newton-John’s choice pot formulas
Health & Biotech
Cannabis: THC Global hits milestone with first cannabis production at Southport
Health & Biotech
Our pets are living longer, happier lives and it’s a $US125bn market; here are the small cap contenders
Health & Biotech
Weed week: Canberra leads the way on cannabis, makes pot possession legal
Health & Biotech
How do you get patients to accept cannabis? Treat it like any other medicine
A host of ASX small caps just got a boost from positive news out of the lab
Health & Biotech
The Pot Seat: Botanix’s Matt Callahan says synthetics are the future of cannabis drugs
Health & Biotech
If pot is so hot, why aren’t cannabis directors buying their own companies?
Health & Biotech
Weed Week: US okays hemp but the Kiwis are eyeing off full legalisation
Health & Biotech
Who’s got those all-important golden cannabis licences and who hasn’t
Health & Biotech
These six Aussie pot stocks raised 70pc of cannabis capital in 2018
Health & Biotech
Pet pot purveyor CannPal gets approval to test drug on dogs at five times doseage
Health & Biotech
Investors cool on cannabis as scandals smoke out fearful traders
Health & Biotech
CannPal is relying on two employees to turn it into a pot star
News